FDA clinical hold on ARD-101, cash-backed valuation, and key catalysts ahead. Click for more on recent developments with AARD ...
Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results